Expression of CYP1A1 and GSTP1 in Human Brain Tumor Tissues in Pakistan
Authors:
- Ishrat MahjabeenIMIshrat Mahjabeen
- Ruqia Mehmood BaigRBRuqia Mehmood Baig
- Mahmood Akhtar KayaniMKMahmood Akhtar Kayani
Open Access
- 31 December 2013
- journal article
- research article
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 14 (12) , 7187-7191
Abstract
Most of the exogenous and endogenous chemical compounds are metabolized by enzymes of xenobiotic processing pathways, including the phase I cytochrome p450 species. Carcinogens and their metabolites are generally detoxified by phase II enzymes like glutathione-S-transferases (GST). The balance of enzymes determines whether metabolic activation of pro-carcinogens or inactivation of carcinogens occurs. Under certain conditions, deregulated expression of xenobiotic enzymes may also convert endogenous substrates to metabolites that can facilitate DNA adduct formation and ultimately lead to cancer development. In this study, we aimed to test the association between deregulation of metabolizing genes and brain tumorigenesis. The expression profile of metabolizing genes CYP1A1 and GSTP1 was therefore studied in a cohort of 36 brain tumor patients and controls using Western blotting. In a second part of the study we analyzed protein expression of GSTs in the same study cohort by ELISA. CYP1A1 expression was found to be significantly high (p<0.001) in brain tumor as compared to the normal tissues, with ~4 fold (OR=4, 95%CI=0.43-37) increase in some cases. In contrast, the expression of GSTP1 was found to be significantly low in brain tumor tissues as compared to the controls (p<0.02). This down regulation was significantly higher (OR=0.05, 95%CI=0.006-0.51; p<0.007) in certain grades of lesions. Furthermore, GSTs levels were significantly down-regulated (p<0.014) in brain tumor patients compared to controls. Statistically significant decrease in GST levels was observed in the more advanced lesions (III-IV, p<0.005) as compared to the early tissue grades (I-II). Thus, altered expression of these xenobiotic metabolizing genes may be involved in brain tumor development in Pakistani population. Investigation of expression of these genes may provide information not only for the prediction of individual cancer risk but also for the prevention of cancer.Keywords
This publication has 29 references indexed in Scilit:
- Predictive Role of Midtreatment Changes in Survivin, GSTP1, and Topoisomerase 2α Expressions for Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast CancerAmerican Journal of Clinical Oncology, 2013
- PHASE II DRUG METABOLIZING ENZYMESBiomedical Papers, 2010
- Endothelial cell responses to atheroprone flow are driven by two separate flow components: low time-average shear stress and fluid flow reversalAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Structure and function of the blood–brain barrierNeurobiology of Disease, 2010
- Glutathione peroxidases in different stages of carcinogenesisBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- Cytochrome P450 CYP1A1: wider roles in cancer progression and preventionBMC Cancer, 2009
- Requirement of Aryl Hydrocarbon Receptor Overexpression for CYP1B1 Up-Regulation and Cell Growth in Human Lung AdenocarcinomasClinical Cancer Research, 2007
- Induction of phase I, II and III drug metabolism/transport by xenobioticsArchives of Pharmacal Research, 2005
- Current epidemiological trends and surveillance issues in brain tumorsExpert Review of Anticancer Therapy, 2001
- Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer susceptibilityCancer Letters, 2000